Travelers Co's William Heyman elected as FINRA chairman
June 29 The Financial Industry Regulatory Authority (FINRA) on Thursday named William Heyman, chief investment officer of Travelers Company Inc, as its chairman, effective July 18.
Dec 12 Elbit Imaging Ltd :
* Gamida Cell informed Co that Gamida Cell has been cleared by FDA to begin enrolling for Phase 3 study of Nicord
* A total of 120 patients will be enrolled at transplantation centers throughout U.S. and Europe for Nicord Phase 3 study
* Gamida Cell has informed Co clearance to begin enrolling for Nicord study has also been received for additional European territory
* Gamida Cell estimates that patient recruitment will take approximately two years to complete Source text for Eikon: Further company coverage:
* H1 REVENUE EUR 36.5 MILLION VERSUS EUR 36.7 MILLION YEAR AGO